These pharmacological activities of α2δ ligands may help to explain their therapeutic activity as supplemental therapy for major depression and depressive symptoms in post-traumatic stress disorder and generalized anxiety disorders ( Valente et al., 2012). This evidence concerns the gene ATXN2L and major depressive disorder.